Comparator: A: Pregabalin + Comparator: B: Duloxetine + Comparator: C: Diphenhydramine hydrochloride
Phase 2Withdrawn 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Painful Diabetic Neuropathy
Conditions
Painful Diabetic Neuropathy
Trial Timeline
Apr 1, 2009 → Sep 1, 2009
NCT ID
NCT00837941About Comparator: A: Pregabalin + Comparator: B: Duloxetine + Comparator: C: Diphenhydramine hydrochloride
Comparator: A: Pregabalin + Comparator: B: Duloxetine + Comparator: C: Diphenhydramine hydrochloride is a phase 2 stage product being developed by Merck for Painful Diabetic Neuropathy. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00837941. Target conditions include Painful Diabetic Neuropathy.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00837941 | Phase 2 | Withdrawn |
Competing Products
20 competing products in Painful Diabetic Neuropathy